Skip to content

Drug interactions

Olutasidenib + Tacrolimus

Severity: Major

Olutasidenib and Tacrolimus: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Olutasidenib induces CYP3A4 and may lower tacrolimus concentrations. Subtherapeutic tacrolimus raises the risk of graft rejection or graft-versus-host disease.

What this interaction means in plain words

Olutasidenib and Tacrolimus can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Olutasidenib belongs to Oncology; Tacrolimus belongs to Miscellaneous.

Evidence level: Moderate

Why it happens

Induction of CYP3A4 increases the metabolic clearance of tacrolimus.

What to do

Avoid if possible. If needed, monitor tacrolimus trough concentrations frequently and increase the dose as required, and reduce it again after olutasidenib is stopped.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Olutasidenib and Tacrolimus, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Olutasidenib with Tacrolimus?

MediHelp rates the interaction as major. Olutasidenib and Tacrolimus can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Olutasidenib induces CYP3A4 and may lower tacrolimus concentrations. Subtherapeutic tacrolimus raises the risk of graft rejection or graft-versus-host disease.

How serious is the interaction between Olutasidenib and Tacrolimus?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if possible. If needed, monitor tacrolimus trough concentrations frequently and increase the dose as required, and reduce it again after olutasidenib is stopped.

What other medicines interact with Tacrolimus?

MediHelp also lists interactions of Tacrolimus with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Cidofovir. The full list is on the Tacrolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in